VoLUME
8, ISSUE 5
september
2003
September 9th Meeting:
The East Bay Headache
Support Group is pleased to have Michael J. Nelson, MD, as our guest speaker on
September 9,
Dr. Nelson is a neurologist
in private practice at the Neurology Medical Group of Diablo Valley, with
offices in Walnut Creek and Concord. He
has been a subinvestigator in many research studies, evaluating the
effectiveness of new drugs in treating various neurological disorders.
We will be meeting in the
Ball Auditorium, downstairs at
5th
Annual
Women’s
Health Fair
Visit the Women’s
Health Fair presented by the Women’s Health Center, part of the John
Muir/Mt. Diablo Health System. This FREE event will be held 2 days this
year, Saturday and Sunday, October 18 and 19, from 11:00 a.m. to 4:00 p.m.
Stop in to say hello
at the East Bay Headache Support Group booth, and then check out the other
resources and businesses which offer services and products specific to women and
their families.
Leslie Griffith, award
winning FOX 2 News Anchor, will speak at the opening ceremonies on Saturday at
11:00 a.m.
As a prelude to the Health
Fair, the Women’s Health Center is presenting a series of FREE evening
lectures by area experts on women’s health issues.
All lectures are held at the Women’s Health Center from 6:30-8:00 p.m.
Space is limited—Please call 925-941-7900, #3 for reservations.
Sept
9: Minimally Invasive Approaches to Hysterectomy
Sept 10:
Infertility Update 2003 — What’s New!
Sept 17:
Menopause: Debunking the
Myths-
Sept
24: Headaches Through the Decades of a Woman’s Life—
Sept 25:
HRT:
The Good, the Bad and the Confusing!
Oct 7: Are You at Risk? Finding Out Your Real Risk for
Breast Cancer
The
Over-the-Counter Risk
They’re cheap, they’re
easily accessible, and there are so many kinds to try. Most of us have two or three brands in our medicine cabinets.
No doctor’s prescription needed and often quick relief.
They, of course, are over-the-counter (OTC) pain medications.
Close to 60% of migraine sufferers self-medicate with OTCs and it’s now
a multi-billion dollar
But while analgesics may
seem safe, these quick fixes can actually pull you into the quicksand of rebound
headache. In fact, the overuse of
analgesic medications is responsible for the majority of cases of chronic daily
headache. Short-term pain relief
reached for too frequently and over an extended period of time can lead to a
long-term headache.
Rebound headache has also
been called medication-overuse headache, analgesic-induced headache, and
refractory head-ache. It describes
a condition in which patients experience daily or almost-daily headache as a
result of overusing pain relief medications, and who experience
The Problem May Be in Your Medicine Cabinet
While there are varying
opinions as to which medications cause rebound, Dr. Tim Smith, Medical
Director of
In other words, any of the
immediate headache relief medications—analgesics, barbiturates, ergots,
triptans, and caffeine—if overused can lead to rebound.
The greatest problems seem to be associated with OTC caffeine-containing
analgesics (even those marketed for migraine) and barbiturate-containing
analgesics.
While rebound can develop
more quickly with triptans than with OTC analgesics, overuse of triptans is
rarer due to the higher costs and limits placed on their use by healthcare
providers and insurance plans. Anti-inflammatories
are generally not associated with rebound, especially the longer-acting
prescriptions. However, even
ibuprofen, plain acetaminophen and aspirin can be triggers.
“It does happen,” said Dr. Smith.
“I’ve seen it, but it’s not as likely.”
The current belief is that
three or more doses of simple analgesics per day for five days or more per week
can lead to rebound. Sedatives,
caffeine or triptans taken three or more days per week can cause the condition
as can opioids or ergotamines taken two or more days
Rebound is an insidious
condition based on a cumulative effect. It
develops slowly, over weeks, months or years, and is rarely recognized by the
person caught in the cycle, or even by their healthcare provider, who may be
unaware that the patient is taking OTCs
A Self-Perpetuating Problem
While the underlying
pathology of rebound is still not completely understood, new scientific
observations are helping unravel the mystery.
Research has shown that when an individual takes repeated doses of
analgesics, which lower serotonin levels, the brain reacts by multiplying the
number of serotonin receptors, especially the 5HT2 receptors.
These 5HT2 receptors are responsible for bringing on migraine.
“In a nutshell,” said
Dr. Smith, “when used in a repeated fashion over time, simple analgesics alter
serotonin levels in the blood and brain, leading to a chain of events that cause
a hyperalgesic state, meaning a high sensitivity to pain.”
Dr. Smith noted that people
who don’t have migraine and take analgesics for such conditions as chronic
back pain or arthritis don’t get rebound. “With migraine you already have a defective
Rebound, then, is a
self-perpetuating condition. Over
time, the headache patient develops a tolerance to the offending analgesic and
so she/he increases the dose. This
alters the serotonin balance even more and the headaches return.
The patient ups the dose once again and the cycle continues.
“My record holder was a
woman who was taking 35 OTC tablets per day,” said Dr. Smith.
“The amount she took grew progressively over years, but by the time I
saw her nothing was working for her headaches and she was miserable.”
High doses of analgesics can
have other ramifications. Gastric
irritation (heart burn, stomach aches), sleep disturbance from caffeine, and
mood changes (possibly due to serotonin changes) are the most common.
Dr. Smith added that there are hidden effects as well.
Some analgesics taken over time can be injurtious to the kidneys and the
liver, while aspirin thins the blood and puts patients at risk for bleeding
ulcers.
Of course, nobody develops
rebound on purpose. “They’re
just trying to get through their day,” said Dr. Smith.
How to Know if It’s Rebound
As the condition worsens,
patients often start taking pain medications in an anticipatory fashion, say
before going to work. Some will
even set their alarm clocks for the middle of the night in order to take another
dose so they won’t wake up with a headache.
If you’ve reached this point, it’s a fairly clear indication that
your solution is in fact your
problem.
“If a patient is taking
medications more than two times per week for more than three months,” Dr.
Smith said, “they’re probably already in trouble.”
Since there’s no blood
test for rebound, the diagnosis can actually only be made in retrospect, once a
patient has withdrawn from the offending medication(s) and relief is obtained.
But there are other clues.
Often the sufferer has a
history of migraine. Over time,
migraine symptoms such as nausea and noise and light sensitivity diminish and
headache of a duller nature become more frequent. Preventive medications do not have any effect on patients
with rebound and stopping the medications for a few days does not resolve the
problem—in fact, it often temporarily makes the headache worse (hence the term
“rebound”).
Once the condition is
established, the pain medication does not need to be taken daily.
At that point, rebound headaches will continue if the drug is taken as
infrequently as once a week or even, in some cases, once a month.
Breaking the Cycle
Here’s the
kicker—without complete discontinuation of the offending medication(s),
rebound headache is almost impossible to get rid of, but it takes up to three
months for serotonin levels in the brain to normalize and rebound head-ache to
resolve. “Three months is a
Treating rebound takes time
and patience. Patients must
completely avoid using analgesics not only for headaches but other painful
conditions. Some patients are able
to use the “cold turkey” approach, but others may need bridging or
transition programs, which use medications to lessen the blow. About half of rebounders will notice an increase in the
intensity of their headaches for one to two weeks.
Because those first two weeks are always the hardest, that’s the most
important time for healthcare providers to be involved.
“Studies show that
patients who make nonpharmacologic changes, as well as taking preventives, do
better with the detox,” said Dr. Smith. These
nonpharmacological approaches include biofeedback to lower stress levels,
regular sleep, and healthy eating.
Dr. Smith noted that after
breaking the cycle, patients feel like they’re coming out of a fog.
“A cloud has been lifted; they look brighter.”
About 75% of patients who go
through withdrawal will revert back to an intermittent pattern of headaches that
are more treatable. However, one
third will start taking OTCs intermittently and end up back in a rebound
pattern.
The message is, once you get
detoxed, don’t go back. Better
yet, don’t get started in the first place.
Having seen so many patients
suffering from rebound headaches, headaches specialists know how important it is
to get the message out about the condition in order to stop rebound before it
starts. “This is the biggest
problem we face,” said Dr. Smith. “Not
enough people know about this. Patients
don’t pay
WHEN IS IT OK TO TAKE OVER-THE-COUNTER MEDICATIONS?
Acetaminophen,
aspirin, ibuprofen, and aspirin/acetaminophen/caffeine combination products have
all been shown to be more effective than placebo at reducing moderate to severe
migraine pain within two hours. So,
“If a patient gets a good response from them, then that’s #1,” says Dr.
Smith.
The
general rule of thumb is don’t take analgesics more than two times per week.
If you are, that’s a warning sign.
According
to Richard Wenzel, pharmacist at the Inpatient Headache Unit at St. Joseph’s
Hospital in Chicago, whose
Since
the majority of migraine sufferers experience disability—defined as an
inability to perform routine job, school, and/or household activities, and/or
the need for bedrest—OTC therapy is usually inadequate.
Wenzel notes that for migraine sufferers who experience disability during
fewer than half of their migraine attacks and/or vomiting in fewer than 20% of
attacks, sole use of OTCs may be a viable treatment option.
The
best candidates for OTC use are those with tension-type headache
characteristics—a constant, dull ache on both sides of the head, mild to
moderate in intensity, possibly accompanied by sensitivity to either lights or
noise, but not both.
Wenzel
counsels patients to treat a minimum of three attacks with a new OTC.
If the drug doesn’t work in at least two out of three attempts, try a
new one. If two or more OTCs have
been tried without success, speak to a physician or headache specialist.
By Lesley
Reed
Excerpted
from the May/June 2003 issue of NHF HeadLines, a bimonthly publication of
the National Headache Foundation. On
the Internet at www.headaches.org